应激状态下NO的胃粘膜保护作用及其与壁细胞泌酸的关系

目的:探讨应激状态下一氧化氮(NO)的胃粘膜保护作用及其与壁细胞泌酸的关系.方法:采用水浸-束缚应激(WRS)方法制备应激性溃疡(SU)动物模型,检测胃粘膜溃疡指数(UI)、胃粘膜NO含量和壁细胞H ,K -ATPase活性,观察L-硝基精氨酸甲酯(L-NAME)和L-精氨酸(L-Arg)对应激后大鼠壁细胞H ,K -ATPase活性及胃粘膜损伤的影响.结果:L-NAME(20 mg·kg-1)可使胃粘膜NO含量减少(P＜0.01),壁细胞H ,K -AT-Pase活性增加(P＜0.05),并加重应激所致的胃粘膜损伤;L-Arg(300 mg·kg-1)则使胃粘膜NO含量增加(P＜0.01),壁细胞H ,K -ATPase活性下降(P＜0.05),减轻应激所致胃粘膜损伤.结论:NO对应激状态下大鼠胃粘膜具有保护作用,其机制与抑制壁细胞H ,K -ATPase活性有关.     

大豆甙元磺酸钠对胃运动的影响及其机制

目的:研究大豆甙元磺酸钠对胃运动的影响及其作用机制。方法:采用SD大鼠腹腔和侧脑室给药,记录胃运动收缩的幅度和频率。结果:①腹腔注射不同剂量的大豆甙元磺酸钠,均引起胃收缩幅度下降,但未呈现剂量效应关系;胃收缩频率无明显变化。②腹腔注射纳洛酮可反转大豆甙元磺酸钠的作用。③腹腔注射心得安,可使大豆甙元磺酸钠抑制胃运动的作用增强,注射酚妥拉明可反转大豆甙元磺酸钠的作用。④腹腔注射阿托品对大豆甙元磺酸钠的作用无明显的影响。⑤侧脑室注射不同剂量的大豆甙元磺酸钠,其中小剂量组出现胃收缩幅度下降,但胃收缩频率亦无明显变化。结论:腹腔和侧脑室注射大豆甙元磺酸钠对胃运动均有抑制作用,且腹腔注射大豆甙元磺酸钠的效应至少部分是与内源性阿片肽及其受体和去甲肾上腺素能神经元及其α受体有关,肾上腺素能神经元及β肾上腺素能受体也参与了大豆甙元磺酸钠抑制胃运动的作用。     

捕食应激过程中大鼠脑边缘系统一氧化氮合酶神经元的变化

探讨应激状态下大鼠脑边缘系统内一氧化氮合酶 (Nitricoxidesynthase,NOS )阳性神经元的变化及这种变化与脑神经元损伤发生的关系。采用捕食应激动物模型 ,将 80只雄性SD大鼠随机分为 3组 :对照组 (n =2 0 )、单纯捕食应激组 (n =30 )、加强捕食应激组 (n =30 )。采用还原型尼克酰胺腺嘌呤二核苷酸黄递酶(NADPH d)组织化学方法 ,研究应激后 1、 3、 6、 12、 2 1、 30dNOS阳性神经元的分布规律。结果表明 :对照组NOS活性平稳 ,但应激后NOS活性变化明显。与对照组比较 ,应激 1- 3d ,单纯应激组和加强应激组NOS阳性神经元数目在皮质、纹状体、海马、下丘脑等部位增多 ,即NOS活性升高 ;第 4 - 12d ,NOS活性进一步升高 ,除皮质外与对照组相比具显著性差异 (P <0 0 1) ;其中 ,应激单纯组和加强组海马和下丘脑室旁核分别在第 6d、第 12dNOS活性最高。从第 13d起NOS阳性神经元的活性开始逐渐降低 ;到第 30dNOS活性下降明显 ,但其活性仍高于对照组 (P <0 0 5 )。对于同一时间点而言 ,与对照组相比 ,加强应激组的NOS活性变化大于相应的单纯应激组。结果提示 :NOS活性程度与心理应激程度密切相关 ;应激过程中大鼠脑边缘系统过量增多的NO产生的神经毒性可能是应激导致大鼠脑边缘系统神经元受损的原因之一     

人胎胃壁内NOS阳性神经元发育的研究

研究用NADPH-d组织化学法对第3个月胎龄至足月人胎胃壁内NOS阳性神经元的分化,迁移和生长发育进行了观察。结果表明：第5个月龄时,肌层神经节处的圆形细胞出现一氧化氮合酶（nitric oxide synthase,NOS)阳性反应。第6个月龄时,NOS阳性细胞分化演变成NOS阳性神经细胞,细胞呈圆形或椭圆形,核大,细胞质极少,由细胞发出短小的6个月龄时,NOS阳性细胞分化演变成NOS阳性神经细胞,细胞呈圆形或椭圆形,核大,细胞质极少,由细胞发出短小的突起,有部分NOS阳性细胞分化演变成梭形的NOS阳性神经细胞,呈条索状排列和粘膜下层延伸,吸的到达粘膜层,在粘膜层形成网状细胞,第7个月龄时,神经元细胞明显增大,细胞质增多,染色加深,在肌层形成神经节,神经节细胞突起投射到整个肌层,第8-10个月龄时,肌层和粘膜下层神经元日趋成熟,细胞质增多,染色强度加深,肌层神经纤维分布密度增加,大多数神经纤维增粗,有的呈弹簧样弯曲,其走向与肌纤维长轴平行。结果提示;人胎胃壁内NOS阳性神经元来源于胚胎早期肌层神经节处的圆形细胞,通过分化,生长发育形成成熟的NOS阳性神经元。     

中脑导水管周围灰质NO在应激大鼠高血压形成中的作用及其机制探讨

目的：探讨大鼠中脑导水管周围灰质（PAG）内NO在应激性高血压（SIH）发病中的作用。方法：采用电击足底结合噪声建立应激性高血压大鼠模型,NADPH－d组化方法显示PAG内一氧化氮合酶（NOS）阳性神经元的变化,核团微注法和放免法检测PAG内微量注射L－NNA对动物血压和延髓头端腹外侧区（RVLM）内Ach含量的影响。结果：（1）应激性高血压大鼠血压升高,PAG背外侧区NOS阳性神经元数量明显减少,平均灰度值增高,且RVLM内Ach含量也增多。（2）PAG内微量注射L－NNA 100mmol/L 0.1μl后,对照组大鼠的平均动脉压（MAP）升高,RVLM内Ach含量增多,而应激性高血压组大鼠MAP的变化显著小于对照组。结论：应激性高血压大鼠PAG内NOS阳性神经元发生的可塑性变化,可能经RVLM内Ach介导,参与了该病的形成。     

急性力竭运动对大鼠胃肠传输速率及回肠肌间神经丛氮能神经的影响

目的：研究力竭运动对大鼠胃肠动力的影响及其肠神经机制。方法：24只大鼠随机分成对照组和急性力竭运动组,建立力竭运动大鼠模型,测定胃肠传输速率,用酶组织化学方法和计算机图像分析技术对两组大鼠回肠肌间神经丛内氮能神经元的数目和一氧化氮合酶（NOS）的表达进行测定。结果：急性力竭运动组大鼠胃肠传输速率明显延迟,回肠肌间神经丛内氮能神经元的数目明显增多和NOS的表达显著增强（P〈0．05和P〈0．01）。结论：大鼠力竭运动后小肠肌问神经丛内氮能神经元的数目增多和NOS的表达增强可能是导致胃肠传输速率延迟的重要原因之一。     

白藜芦醇甙对大鼠心脏缺血/再灌注损伤的保护作用

本文利用冠脉结扎/放松方法和Langendorff灌注技术,建立在体和离体大鼠心脏缺血/再灌注(ischemia/reperfusion,I/R)损伤模型,探讨白藜芦醇甙(polydatin)对大鼠I/R心肌损伤的保护作用及其机制.观察白藜芦醇甙对缺血和再灌注心律失常、心肌梗死面积、心脏收缩功能、心肌超氧化物歧化酶(superoxide dismutase,SOD)活性、丙二醛(malondialdehyde,MDA)含量、NO含量以及一氧化氮合酶(nitric oxide synthase,NOS)活性的影响.结果显示:与对照组相比,白藜芦醇甙组大鼠缺血和再灌注心律失常明显降低(P<0.05,P<0.01);心肌梗死面积显著减少(P相似文献   

CNTF对烧伤大鼠血清引起大鼠海马神经元细胞毒性的影响

应用整体和离体神经元培养,观察CNTF对烧伤大鼠海马神经元及烧伤血清引起海马神经元损伤的影响,结果表明,大鼠烧伤后海马组织神经元数目减少,NO含量升高;烧伤大鼠血清可引起培养的海马神经元细胞存活率下降,培养液中NO含量升高;CNTF能降低烧伤大鼠海马组织中NO的含量,保护海马神经元,并能提高培养的海马神经元的存活率,减少培养液中NO含量,其作用呈剂量依赖性;CNTF对神经元存活率的影响与NO含量呈显著负相关,提示CNTF对烧伤大鼠血清引起的海马神经元损伤有保护作用,其作用机制可能是通过抑制NO的神经毒性。     

海马微量注射神经肽Y通过抑制一氧化氮合酶改善大鼠抑郁样行为

本文旨在探讨在慢性应激性抑郁发生过程中海马神经肽Y(neuropeptide Y,NPY)和一氧化氮合酶(nitric oxide synthase,NOS)的关系。建立慢性不可预见性温和应激(chronic unpredictable mild stress,CUMS)抑郁模型,大鼠海马定位并分别微量注射NPY、NPY-Y1受体阻断剂GR231118和NOS抑制剂L-NAME,测量、计算动物体重变化并通过糖水偏爱测试、旷场和强迫游泳实验等方法检测大鼠行为,免疫组织化学方法检测海马内NPY、神经元型NOS(neuronal nitric oxide synthase,nNOS)和诱导型NOS(inducible nitric oxide synthase,iNOS)的表达。结果显示,与对照组相比,CUMS组大鼠表现出明显的抑郁样行为变化,且海马NPY表达下降、NOS表达显著升高;海马微量注射NPY明显改善应激引起的抑郁样行为表现,并降低海马NOS表达;用GR231118选择性阻断NPY-Y1受体后,大鼠的行为学表现能力下降,海马NOS表达升高;而CUMS以及GR231118所导致的行为学表现能力下降的现象均可被海马微量注射L-NAME所反转。以上结果表明,CUMS引起海马NPY表达下降,NOS表达升高,NO过量产生,导致抑郁发生;而NPY通过NPY-Y1受体抑制NOS的过量表达是NPY抗抑郁的一个重要途径。     

急性给锂小鼠大脑皮层NOS活性与蛋白表达的时程变化

目的探讨急性给锂小鼠大脑皮层一氧化氮合酶(NOS)活性与蛋白表达的时程变化及其意义.方法选用昆明小鼠40只,分为对照组和腹腔注射1.5mmol/Kg氯化锂(LiCl)即刻、0.5h、1h、3h、6h、12h、24h组,每组5只.采用NADPH-d黄递酶组织化学和ABC免疫组化法,观察急性给锂后不同时程小鼠大脑皮层NOS和nNOS阳性神经元数目的变化.结果急性给锂即刻小鼠大脑皮层NOS和nNOS阳性神经元数目明显增加(P＜0.01),1h后达到高峰(P＜0.01),6h和12h恢复到正常水平(P＞0.05),24hNOS阳性神经元又明显增高(P＜0.01),nNOS阳性神经元处于正常水平(P＞0.05).结论本实验提示急性给锂对小鼠大脑皮层NOS和nNOS阳性神经元数目有一定影响,这种变化可能是锂影响脑发育及锂的神经毒性的机理之一.     

NO参与玉米幼苗对盐胁迫的应答

以玉米幼苗为材料,研究盐胁迫下其內源NO含量、NR和NOS活性的变化;NOS专一性抑制剂L-NAME和NR非专一性抑制剂NaN3对玉米幼苗內源NO含量的影响;利用激光共聚焦显微技术观测盐胁迫下玉米幼苗根部NO含量的变化及其分布特点。结果表明,盐胁迫下玉米幼苗根尖和叶片中NO含量有猝发现象,NOS活性也随之显著提高,NR活性则显著降低;L-NAME或NaN3均可降低盐胁迫所引起的玉米幼苗NO水平的增加,L-NAME对NO含量的影响比NaN3更显著。推测,NO参与玉米幼苗对盐胁迫的应答,NOS途径是盐胁迫下玉米幼苗內源NO合成的主要途径。     

Gastroprotective and vasodilatory effects of epidermal growth factor: the role of sensory afferent neurons

Epidermal growth factor (EGF) has been shown to exert gastric hyperemic and gastroprotective effects via capsaicin-sensitive afferent neurons, including the release of calcitonin gene-related peptide (CGRP). We examined the protective and vasodilatory effects of EGF on the gastric mucosa and its interaction with sensory nerves, CGRP, and nitric oxide (NO) in anesthetized rats. Intragastric EGF (10 or 30 microg) significantly reduced gastric mucosal lesions induced by intragastric 60% ethanol (50.6% by 10 microg EGF and 70.0% by 30 microg EGF). The protective effect of EGF was significantly inhibited by pretreatment with capsaicin desensitization, human CGRP1 antagonist hCGRP-(8-37), or N(omega)-nitro-L-arginine methyl ester (L-NAME). Intravital microscopy showed that topically applied EGF (10-1,000 microg/ml) dilated the gastric mucosal arterioles dose dependently and that this vasodilatory effect was significantly inhibited by equivalent pretreatments. These findings suggest that EGF plays a protective role against ethanol-induced gastric mucosal injury, possibly by dilating the gastric mucosal arterioles via capsaicin-sensitive afferent neurons involving CGRP and NO mechanisms.     

脑室内注射一氧化氮供体及一氧化氮合酶抑制剂对室旁核大细胞自发电活动的作用

在乌拉坦麻醉的成年ＳＤ大鼠上,用玻璃微电极细胞外记录的方法,观察了脑室内注射一氧化氮供体及一氧化氮合酶抑制剂对室旁核大细胞自发电活动的作用。结果发现：脑室内注射一氧化氮供体硝普钠对下丘脑室旁核中的加压素神经元产生剂量依赖性抑制作用;脑室内注射一氧化氮合酶抑制剂对加压素神经元也产生抑制作用。上述两种药物对催产素神经元均无作用。这些结果提示：一氧化氮可能在调节加压素和催产素神经元活动中起着不同的作用。     

Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.

We investigated the role of nitric oxide (NO) in the interleukin 1beta (IL-1beta) and nicotine induced hypothalamic-pituitary-adrenal axis (HPA) responses, and a possible significance of CRH and vasopressin in these responses under basal and social stress conditions. Male Wistar rats were crowded in cages for 7 days prior to treatment. All compounds were injected i.p., nitric oxide synthase (NOS) inhibitors, alpha-helical CRH antagonist and vasopressin receptor antagonist 15 min before IL-1beta or nicotine. Identical treatment received control non-stressed rats. Plasma ACTH and serum corticosterone levels were measured 1 h after IL-1beta or nicotine injection. L-NAME (2 mg/kg), a general nitric oxide synthase (NOS) inhibitor, considerably reduced the ACTH and corticosterone response to IL-1beta (0.5 microg/rat) the same extent in control and crowded rats. CRH antagonist almost abolished the nicotine-induced hormone responses and vasopressin antagonist reduced ACTH secretion. Constitutive endothelial eNOS and neuronal nNOS inhibitors substantially enhanced the nicotine-elicited ACTH and corticosterone response and inducible iNOS inhibitor, aminoguanidine, did not affect these responses in non-stressed rats. Social stress significantly attenuated the nicotine-induced ACTH and corticosterone response. In crowded rats L-NAME significantly deepened the stress-induced decrease in the nicotine-evoked ACTH and corticosterone response. In stressed rats neuronal NOS antagonist did not alter the nicotine-evoked hormone responses and inducible NOS inhibitor partly reversed the stress-induced decrease in ACTH response to nicotine. These results indicate that NO plays crucial role in the IL-1beta-induced HPA axis stimulation under basal and social stress conditions. CRH and vasopressin of the hypothalamic paraventricular nucleus may be involved in the nicotine induced alterations of HPA axis activity. NO generated by eNOS, but not nNOS, is involved in the stress-induced alterations of HPA axis activity by nicotine.     

Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer.

The role of nitric oxide in ulcer formation remains unknown. Accordingly, we assessed local expression of inducible nitric oxide synthase (NOS) and nitration of tyrosine as an indicator of peroxynitrite formation in patients with Helicobacter pylori (HP)-associated gastric ulcers compared with HP-negative ulcers. Biopsy specimens were taken from the ulcer margin and from an area remote from the ulcer portion. Inducible NOS, nitrotyrosine, and macrophage immunoreactivity were assessed immunohistochemically using a labeled streptavidin-biotin method. In HP-positive gastric ulcers, inducible NOS and nitrotyrosine immunoreactivity was frequently observed at active ulcer margins, sometimes in surface epithelial cells as well as in the lamina propria. Occasionally, inducible NOS and nitrotyrosine reactivity were found in areas remote from the lesion in cases of HP-positive ulcer and HP-related gastritis. Macrophages accumulated significantly in the margin of HP-positive ulcers. In HP-negative gastric ulcers, inducible NOS and nitrotyrosine immunoreactivity also were frequent at the ulcer margin, but no significant immunoreactivity was observed at a distance. HP eradication caused significant attenuation in inducible NOS and macrophage immunoreactivity. In conclusion, nitric oxide and peroxynitrite formation is increased in HP-infected gastric mucosa, suggesting that HP promotes nitric oxide stress.     

Prevention of doxorubicin-induced damage to rat heart myocytes by arginine analog nitric oxide synthase inhibitors and their enantiomers

The clinical use of the widely used anticancer drug doxorubicin is limited by a dose-dependent cardiotoxicity. Doxorubicin can be reduced to its semiquinone free radical form by nitric oxide synthases (NOS). The release of lactate dehydrogenase (LDH) from doxorubicin-treated neonatal cardiac rat myocytes was used as a model of doxorubicin-induced cardiotoxicity. The NOS inhibitors N(G)-nitro-L-arginine methyl ester (L-NAME) and N(G)-monomethyl-L-arginine (L-NMMA) protected myocytes from doxorubicin as did their non-inhibitory enantiomers D-NAME and D-NMMA. Thus, these agents did not protect by inhibiting NOS. L-NAME, which does not act at the reductase domain of NOS, also had no effect on the production of the doxorubicin semiquinone by myocytes. Nitric oxide (NO) EPR spin trapping experiments showed that L-NAME reacted with various biological reducing agents to produce NO. Ascorbic acid was highly effective in reacting with L-NAME to produce NO, while glutathione, NADPH, and NADH were much less effective. Thus, these guanadino-substituted analogs of L-arginine likely protected through their ability to slowly produce NO by reaction with intracellular ascorbic acid. Thus, some caution must be exercised in their use. NO may exert its protective effects either by directly acting as an antioxidant or through some other NO-dependent pathway.     

大鼠实验性乙醇胃粘膜损伤中一氧化氮合成酶和内皮素合量的变化及意义

目的 :探讨一氧化氮和内皮素在急性乙醇胃粘膜损伤中的作用及其相互关系。方法 :采用大鼠乙醇胃粘膜损伤模型 ,测定其胃粘膜内一氧化氮合成酶 (NOS)和内皮素 (ET)含量并观察其胃粘膜病理变化。结果 :随着乙醇作用时间延长和胃粘膜损伤的加重 ,胃粘膜内ET含量显著上升 (P <0 .0 5 ) ,而NOS的含量显著下降 (P <0 .0 5 ) ,两者呈负相关。结论 :胃粘膜内ET释放增加和NOS活性下降参与了急性乙醇胃粘膜损伤的病理生理过程。     

The effect of L-NAME administrations after oral mucosal incision on wound NO level in rabbit

The aim of the current study was to comparatively investigate the effect of inhibition of nitric oxide (NO) production by N-nitro-L-arginine methyl ester (L-NAME), an isoform non-specific inhibitor of nitric oxide synthase (NOS), after oral mucosal incision on wound tissue NO levels. A standard incision was applied to the oral mucosa of rabbits. After oral mucosal incision, rabbits were divided into five groups as follows: (1) Untreated incisional group (control); (2) Titanium (Ti) implanted group; (3) Ti + Polyethylene glycol (PEG) 4000 implanted group; (4) Ti + PEG 4000 + L-NAME (2 × 10⁻⁴ M) implanted group and (5) i.p. L-NAME administrated group (10 mg/kg). At 5 days after oral incision operations, wound tissue strips and plasma were obtained from rabbits. Oral wound tissue and plasma nitric oxide, plasma thiobarbituric acid reactive substances (TBARS) and total sulfhydryl group (RSH) levels were investigated. Plasma TBARS and NOx levels decreased after i.p. L-NAME administration. Total RSH group levels were not changed in all groups (p>0.05). This means that L-NAME inhibits the deteriorating effects of free radicals without affecting healing. L-NAME in PEG and titanium also has no effect on tissue and plasma NOx levels. These findings indicate that NO generation will not be affected both Ti and local nitric oxide synthase (NOS) inhibitor. (Mol Cell Biochem 278: 65–69, 2005)     

Preservation of neurological functions by nitric oxide synthase inhibitors in conscious rats following delayed hemorrhagic shock

Excessive production of nitric oxide (NO) as result of inducible nitric oxide synthase (iNOS) induction has been implicated in the pathophysiology of hemorrhagic shock. Our aim was to study the effects of NOS inhibitors, aminoguanidine (AG) and NG-nitro-L-arginine methyl ester (L-NAME), on survival rate, mean arterial blood pressure (MABP), temporal evolution of infarct volume, nitric oxide (NO) production and neurological deficit in a model of delayed hemorrhagic shock (DHS) in conscious rats. Our results showed that the NOS inhibitors significantly improved survival rate, MABP, and attenuated brain NO overproduction 24, 48 h and 72 h after DHS. AG reduced brain infarct volume and improved the neurological performance evaluated by the rotameric and grip strength tests while L-NAME did not show protective effect in rats following DHS. These findings suggest that NO formation via iNOS activation may contribute to organ damage and that the selective iNOS inhibitor, AG, may be of interest as a therapeutic agent for neurological recovery following DHS.